Search results: 7174

  1. Poster Public and Patient Involvement (PPI) bench to bedside: developing a PPI model across multiple areas of research

    Cleary K, Nelson A, Fitzgibbon J, Seddon K

    Background: The Wales Cancer Research Centre (WCRC) is funded by the Welsh Government and covers the wide breadth of cancer research. Public and patient involvement (PPI) is an integral component of the WCRC and is considered to be the ‘golden thread’, woven into the centre’s work. Objective: We wanted to develop a model of PPI that is easily ...

  2. Poster The impact of low back pain clinical trials measured by the Altmetric score: cross-sectional study

    Costa Araujo A, Port Nascimento D, Zoldan Gonzalez G, Maher CG, Oliveira Pena Costa L

    Background: There is interest from authors and publishers in sharing the results of their studies over the internet in order to increase their readership. In this way, articles tend to be discussed and the impact of these articles tends to be increased. In order to measure this type of impact a new score (named Altmetric) was created. Altmetric aims ...

  3. Oral Machine learning tools to expedite citation screening and risk of bias appraisal in systematic reviews: evaluations of Abstrackr and RobotReviewer

    Gates A, Vandermeer B, Johnson C, Hartling L

    Background: Abstrackr and RobotReviewer are emerging tools that semi-automate citation screening and 'Risk of bias' (RoB) appraisal in systematic reviews (SRs). Objectives: We compared the reliability of Abstrackr’s predictions of relevant records and of RobotReviewer’s RoB judgments to human reviewer consensus. Methods: We used a convenience sample ...

  4. Poster A descriptive analysis of non-Cochrane child-relevant systematic reviews published in 2014

    Gates M, Elliott SA, Johnson C, Thomson D, Williams K, Fernandes RM, Hartling L

    Background: Consumers, clinicians, policymakers and researchers require high quality evidence to guide decision making in child health. Though Cochrane systematic reviews (SRs) are a well-established source of evidence, little is known about the characteristics of non-Cochrane child-relevant SRs. Objectives: To complement published descriptions ...

  5. Poster A practical toolkit for clinicians to locate best evidence to improve patient outcomes

    Kendall S, Ryu M, Walsh C

    Background: Sinai Health System (SHS) is an internationally recognized academic health sciences centre affiliated with the University of Toronto. With more than 28,809 admissions a year, clinicians at SHS are often challenged with locating the best available published evidence at the time of need. An overwhelming number of electronic resources are ...

  6. Poster The top clinical research priorities in mental health: implementation and maintainance of a website with free access for researchers, academics, health professionals and consumers in Brazil

    Melnik T, Ferreira I, Peron S, Beatriz Neufeld C, Peccin S, Puga ME

    Background: Many clinical questions about the efficacy, effectiveness of mental disorders remains unanswered, therefore patients, careers and clinicians should work collaboratively to establish the most important research priorities. More often than not, the research agendas in low- and middle-income countries are seen to be driven by researcher interests ...

  7. Oral Priority setting for systematic reviews of interventions for communicable and non-communicable diseases in West Africa: the impact of consumer involvement

    Oduwole OA, Effa E, Meremikwu MM

    Background: To a large extent, Africa - especially sub-Saharan African countries - bears most of the global burden of both communicable and non-communicable diseases. Therefore, it is important to set priorities for systematic reviews of interventions for identified priority conditions, so that scarce and limited resources can be allocated where they ...

  8. Poster Schizophrenia trials in Mexico: are we producing our own evidence?

    Ortiz-Orendain J, Castiello-de Obeso S, Adams CE

    Background: Most of the evidence from randomised clinical trials (RCTs) of schizophrenia comes from countries with different ethnic, cultural and economic backgrounds from Mexico (population ~120 million, lifetime prevalence of schizophrenia ~0.7%). The external validity of these trials might be questionable where it comes to application within Mexico, ...

  9. Oral Node-making processes in network meta-analysis of non-drug treatments

    Shi C, Westby M, Norman G, Dumville J, Cullum N

    Background: Network meta-analyses (NMAs) are common outputs of evidence synthesis. Treatment nodes are integral to network formation and represent the entities being evaluated. Because different node-making methods can alter the network and subsequent results drastically, robust conduct and reporting are needed. There is scope to expand current recommendations ...

  10. Poster Identifying national and sub-national data of maternal cause of death: challenges in epidemiologic searching of bibliographic databases

    Skidmore B, Allen T, Chou D, Ganatra B, Garritty C, Henschke N, Moller AB, Pestridge C, Villanueva G

    Background: Identifying accurate and robust information on causes of maternal death beyond civil registration data requires looking for information in population- and facility-based studies, specialized surveys, registries and elsewhere. Bibliographic databases (BDs) offer one source but current epidemiologic search filters are suboptimal. We explore ...